Cohen-Mansfield J., Billig N.: Agitated behaviors in the elderly: A conceptual review. J Am Geriatr Soc1986 ;34:711-721.
2.
Rabins PV, Mace NL, Lucas MJ: The impact of dementia on the family. JAMA1982;248:333-335.
3.
Zimmer JG, Watson N., Treat A.: Behavioral problems among patients in skilled nursing facilities. Am J Public Health1984;74:1118-1121.
4.
Ray WA, Federspiel CF, Schaffner W.: A study of antipsychotic drug use in the nursing homes: Epidemiological evidence suggesting misuse. Am J Public Health1980 ;70:483-491.
5.
Risse SC, Barnes R.: Pharmacologic treatment of agitation association with dementia. J Am Geriatr Soc1986;34:368-376.
6.
Cohen-Mansfield J.: Agitated behaviors in the elderly: Preliminary results in the cognitively deteriorated. J Am Geriatr Soc1986;34:722-727.
7.
Cole JO, Altesman R., Weingarten C.: Beta blocking drugs in psychiatry. McLean Hosp J 1979;8:40-68.
8.
Elliott FA: Propranolol for the control of belligerent behavior following acute brain damage. Ann Neurol1977;1:489-491.
9.
Petrie WM, Ban TA: Propranolol in organic agitation. Lancet1981 ; 1:324.
10.
Greendyke RM , Schuster DB, Wooten JA: Propranolol in the treatment of assaultive patients with organic brain disease. J Clin Psychopharmacol1984;4:5.
11.
Greendyke RM , Kanter DR: Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: A double blind study. HClin Psychiatry1986;47:423-426.
12.
Foy A., Drinkwater V., Marsh S., Mearrick P.: Confusion after admission to hospital in elderly patients using benzodiazepines . Br Med J1986;293:1072.
13.
Weiler PG, Goodman T.: The use of propranolol in Alzheimer's disease patients with disruptive behavior . Curr Ther Res1987; 42:364-374.
14.
Davies P.: The neurochemistry of Alzheimer's disease in senile dementia. Medicinal Res Rev1983;3:221-236.
15.
Stevens JR, Jermann BP: Temporal lobe epilepsy psychopathology and violence: The state of evidence . Neurology1981;31: 1127-1132.
16.
Mann JJ, Brown RP, Halper JP, et al: Reduced sensitivity of lymphocyte β-adrenergic receptors in patients with endogenous depression and psychomotor agitation. N Engl J Med1985;313:715-720.
17.
Banerje SP, Kung LS, Riggi SJ, Chanda SK: Development of β-adrenergic sensitivity by antidepressants. Nature1977;268:455-456.
18.
Wolfe BB, Harden TK, Sporn JR, Molinoff PB: Presynaptic modulation of β-adrenergic receptors in rats cerebral cortex after treatment with antidepressants. J Pharmacol Exp Ther1978;207:446-457.
19.
Aarons RD, Nies AS, Gal J., et al: Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest1981;65:949-957.
20.
Greenblatt DJ, Schader RI: The psychopharmacology of β-adrenergic blockage. Curr Ther Res1972;14:615-625.
21.
Saelens DA, Wall ET, Privitera PJ, et al: Central nervous system effects in metabolic disposition of a glycometabolite of propranolol. J Pharmacol Exp Ther1974;188:86-92.
